Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

ClinicalTrials.gov ID: NCT01104766

Public ClinicalTrials.gov record NCT01104766. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 2:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo and Active-Controlled Evaluation of the Safety and Efficacy of Cariprazine in the Acute Exacerbation of Schizophrenia

Study identification

NCT ID
NCT01104766
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Forest Laboratories
Industry
Enrollment
617 participants

Conditions and interventions

Conditions

Interventions

  • Cariprazine Drug
  • Aripiprazole Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 22, 2010
Primary completion
Dec 19, 2011
Completion
Dec 19, 2011
Last update posted
Oct 28, 2018

2010 – 2011

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Woodland International Research Group, Inc. Little Rock Arkansas 72211
Woodland Research Northwest, LLC Springdale Arkansas 72764
Synergy Clinical Research of Escondido Escondido California 92025
Excell Research, Inc Oceanside California 92056
Clinical Innovations, Inc. Riverside California 92506
Sharp Mesa Vista Hospital San Diego California 92123
Collaborative Neuroscience Network, Inc. Torrance California 90502
Colorado Clinical Trials, Inc. Littleton Colorado 80130
Comprehensive Clinical Development, Inc. Washington D.C. District of Columbia 20016
Florida Clinical Research Center, LLC Bradenton Florida 34208
Hawaii Clinical Research Center Honolulu Hawaii 96813
Uptown Research Institute, LLC Chicago Illinois 60640
Alexian Brothers Center for Psychiatric Research Hoffman Estates Illinois 60169
Precise Research Centers Flowood Mississippi 39232
Millennium Psychiatric Associates, LLC Creve Coeur Missouri 63141
CRI Worldwide, LLC Willingboro New Jersey 08046
Windsor-Laurelwood Center for Behavioral Medicine Willoughby Ohio 44094
Vanderbilt Psychiatric Hospital Nashville Tennessee 37212
Claghorn-Lesem Research Clinic, Ltd. Houston Texas 77008
Pacific Institute of Medical Sciences Bothell Washington 98011

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01104766, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2018 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01104766 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →